Pharmahungary Group as a Hungarian SME is ready for Horizon 2020 applications and are offering innovative preclinical and clinical R&D services.
Realising the therapeutic potential of novel cardioprotective therapies, COST Action
GCP course by Pharmahungary Group Clinical Director
Pharmahungary Group joins COST Action, CardioRNA
Pharmahungary Group lecture at the Department of Pharmacology and Pharmacotherapy